Daniel Geh

1.4k total citations · 1 hit paper
17 papers, 628 citations indexed

About

Daniel Geh is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Daniel Geh has authored 17 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Daniel Geh's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Immune cells in cancer (4 papers). Daniel Geh is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Immune cells in cancer (4 papers). Daniel Geh collaborates with scholars based in United Kingdom, Türkiye and Malaysia. Daniel Geh's co-authors include Helen L. Reeves, Jack Leslie, Derek A. Mann, Thomas G. Bird, Caroline Gordon, Quentin M. Anstee, Derek Manas, Stuart Hunter, David Adams and Manjit Braitch and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Daniel Geh

16 papers receiving 623 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophils as potential therapeutic targets in hepatocellular carcinoma

2022 142 citations Daniel Geh, Jack Leslie et al. Nature Reviews Gastroenterology & Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Geh United Kingdom	10	244	228	213	143	96	17	628
Amleto Fiocchi Italy	7	220 0.9×	241 1.1×	249 1.2×	158 1.1×	83 0.9×	7	630
Yih-Jyh Lin Taiwan	14	79 0.3×	162 0.7×	122 0.6×	110 0.8×	149 1.6×	23	501
Huiyin Yang China	5	476 2.0×	162 0.7×	169 0.8×	393 2.7×	120 1.3×	7	782
Marta Mainetti Italy	3	217 0.9×	219 1.0×	235 1.1×	128 0.9×	61 0.6×	3	576
Irene Lo China	7	123 0.5×	100 0.4×	101 0.5×	147 1.0×	198 2.1×	9	467
Akhil Chopra Singapore	14	118 0.5×	343 1.5×	139 0.7×	350 2.4×	101 1.1×	27	750
Yufu Ye China	12	151 0.6×	130 0.6×	136 0.6×	155 1.1×	122 1.3×	26	516
Baoyun Fu China	4	639 2.6×	226 1.0×	224 1.1×	492 3.4×	125 1.3×	5	994
Seiji Hosaka Japan	7	143 0.6×	161 0.7×	115 0.5×	140 1.0×	266 2.8×	20	538
Ryan C. Widau United States	10	141 0.6×	99 0.4×	55 0.3×	214 1.5×	152 1.6×	31	468

Countries citing papers authored by Daniel Geh

Since Specialization

Citations

This map shows the geographic impact of Daniel Geh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Geh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Geh more than expected).

Fields of papers citing papers by Daniel Geh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Geh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Geh. The network helps show where Daniel Geh may publish in the future.

Co-authorship network of co-authors of Daniel Geh

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Geh. A scholar is included among the top collaborators of Daniel Geh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Geh. Daniel Geh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Geh, Daniel, et al.. (2025). Improving surgical treatments for hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology. 23(3). 208–226.

Collins, Amy, Erik Ramon‐Gil, Daniel Geh, et al.. (2025). Precision-cut tumor slices for modeling hepatocellular carcinoma enable at-scale drug screening. Hepatology Communications. 9(6). 1 indexed citations

Ramon‐Gil, Erik, Daniel Geh, & Jack Leslie. (2023). Harnessing neutrophil plasticity for HCC immunotherapy. Essays in Biochemistry. 67(6). 941–955. 9 indexed citations

Perone, Ylenia, Shishir Shetty, Maria Qurashi, et al.. (2023). Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study. Cancers. 15(13). 3378–3378. 3 indexed citations

Geh, Daniel, Amy Collins, Saimir Luli, et al.. (2023). Neutrophil degranulation and ageing as potential therapeutic targets in hepatocellular carcinoma?. Journal of Hepatology. 78. S542–S542. 1 indexed citations

Geh, Daniel, et al.. (2022). Neutrophils as potential therapeutic targets in hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology. 19(4). 257–273. 142 indexed citations breakdown →

Leslie, Jack, Daniel Geh, Ahmed M. Elsharkawy, Derek A. Mann, & Michèle Vacca. (2022). Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions. Journal of Hepatology. 77(1). 219–236. 34 indexed citations

Leslie, Jack, Jill V. Hunter, Amy Collins, et al.. (2022). c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis. Hepatology. 78(4). 1050–1063. 7 indexed citations

Torrens, Laura, Carla Montironi, Marc Puigvehí, et al.. (2021). Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology. 74(5). 2652–2669. 107 indexed citations

10.

Geh, Daniel, Quentin M. Anstee, & Helen L. Reeves. (2021). NAFLD-Associated HCC: Progress and Opportunities. SHILAP Revista de lepidopterología. Volume 8. 223–239. 47 indexed citations

11.

Geh, Daniel, Derek Manas, & Helen L. Reeves. (2021). Hepatocellular carcinoma in non-alcoholic fatty liver disease—a review of an emerging challenge facing clinicians. HepatoBiliary Surgery and Nutrition. 10(1). 59–75. 42 indexed citations

12.

Godlee, Alexandra, Daniel Geh, Nick D. Jones, et al.. (2021). Latent Cytomegalovirus Infection and Previous Capsular Polysaccharide Vaccination Predict Poor Vaccine Responses in Older Adults, Independent of Chronic Kidney Disease. Clinical Infectious Diseases. 73(4). e880–e889. 9 indexed citations

13.

Geh, Daniel, et al.. (2019). Weighing the benefits of hepatocellular carcinoma surveillance against potential harms. SHILAP Revista de lepidopterología. Volume 6. 23–30. 13 indexed citations

14.

Geh, Daniel & Caroline Gordon. (2018). Epratuzumab for the treatment of systemic lupus erythematosus. Expert Review of Clinical Immunology. 14(4). 245–258. 33 indexed citations

15.

Jeffery, Hannah C., Bonnie van Wilgenburg, Ayako Kurioka, et al.. (2015). Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. Journal of Hepatology. 64(5). 1118–1127. 167 indexed citations

16.

Loch, Alexander, et al.. (2015). Cardiac magnetic resonance imaging: a tool to diagnose parasitic infection?. European Heart Journal. 37(8). 702–702. 1 indexed citations

17.

Packer, Claire, et al.. (2014). No lasting legacy: no change in reporting of women's sports in the British print media with the London 2012 Olympics and Paralympics. Journal of Public Health. 37(1). 50–56. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact